Impax Labs Enters Commercialization Deal with Perrigo
Impax Laboratories, Inc. (NASDAQ: IPXL) today announced that it will collaborate with Perrigo Company (NASDAQ: PRGO;TASE) on the development, manufacturing and commercialization of an extended topical generic drug product with first to market potential. The product and terms of the agreement were not disclosed.
© 2017 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.